NDC 65250-001 - Zilretta

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC
65250-001
Package NDCs from labels
65250-001-01
Manufacturer
Pacira Pharmaceuticals, Inc.
Effective date
2026-04-02
Current FDA listing
Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
LabelManufacturerEffective dateType
triamcinolone acetonide extended-release injectable suspensionPacira Pharmaceuticals, Inc.2026-04-02HUMAN PRESCRIPTION DRUG LABEL

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
65250-001-01Zilretta1 in 1 VIAL, SINGLE-DOSEINJECTION, POWDER, FOR SUSPENSIO132 mg6

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
65250-001ZILRETTA (TRIAMCINOLONE ACETONIDE EXTENDED-RELEASE INJECTABLE SUSPENSION) KIT [PACIRA PHARMACEUTICALS, INC.]4Unmatched20250112_cd5c4673-21f2-4126-9556-da847b3a228b.zip